Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at an average US$53.53 for US$401K under a trading plan, leaving 278,544 shares. Filed Nov 18, 2026 (Form 4).

Sold
7,500 shares
Price
US$53.53 average (US$53.22 to US$55.21)
Value
US$401K
Holding after
278,544 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockOption exercise7,500US$10.60286,044Direct
Nov 16, 2026Common StockSale5,077US$53.22280,967Direct
Nov 16, 2026Common StockSale2,223US$54.08278,744Direct
Nov 16, 2026Common StockSale200US$55.21278,544Direct

Source

Download original · View original at SEC

Related